Inhibrx Biosciences, Inc. INBX Business Segments — Other General and Administrative Expense

Similar metrics at other companies

NEOReportable Segment — Other General and Administrative Expense

$49.05M-3.4%

GRNDReportable Segment — Other general and administrative expense

$5.66M+44.2%

ACHRReportable Segment — Other general and administrative expense

$42.7M+105%

VCYTReportable Segment — Other general and administrative expenses

$13.47M-38.5%

ENPHReportable Segment — Other general and administrative

$20.35M-4.0%

IMVTReportable Segment — Other general and administrative

$7.14M-34.4%

Questions, answered.

What is Inhibrx Biosciences, Inc.'s business segments — other general and administrative expense?

Inhibrx Biosciences, Inc. (INBX) reported business segments — other general and administrative expense of $2.06M in Q1 2026.

How has Inhibrx Biosciences, Inc.'s business segments — other general and administrative expense changed year-over-year?

Inhibrx Biosciences, Inc.'s business segments — other general and administrative expense decreased by 8.1% year-over-year, from $2.25M to $2.06M.

What does business segments — other general and administrative expense mean?

This metric captures general corporate overhead expenses such as insurance, office utilities, and professional services not tied to specific R&D projects. It provides insight into the fixed costs required to maintain the company's corporate infrastructure. Managing these costs is essential for preserving liquidity in clinical-stage companies.